Ventilator Market by Mobility (ICU, Portable), Type (Adult/Pediatric, Neonatal/Infant), Mode (Combined, Volume, Pressure), Interface (Invasive, Non-invasive), End User (Hospital, Clinic, ACC, Home Care, EMS) & Region - Global Forecast to 2027
The global ventilator market in terms of revenue was estimated to be worth $3.9 billion in 2022 and is poised to reach $5.4 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. In recent years, the ventilators market has evolved significantly due to technological advancements, such as the development of advanced portable ventilators and improvements in the sensor technologies used in ventilators. The increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, growing preference for home-based oxygen therapy, and the outbreak of infectious diseases affecting the respiratory system are expected to drive market growth. The emergence of home healthcare has expanded growth opportunities for the ventilators market. However, shortage of skilled medical workers and the excessive purchase of ventilators are factors expected to restrain the market growth to a certain extent in the coming years.
To know about the assumptions considered for the study, Request for Free Sample Report
Ventilator Market Dynamics
Growth Drivers: Urbanization and rising pollution levels
Exposure to indoor & outdoor air pollutants and allergens is a major risk factor for chronic respiratory diseases. These risks are largely due to smoke and pollutants released by vehicles and industries in cities. Intense and prolonged exposure to dust in industrial operations (especially in coal mining, gold mining, and cotton textile operations) and exposure to chemicals such as cadmium, isocyanates, and fumes from welding cause airflow obstruction; this is prevalent in even non-smokers.
As per the WHO, around 91% of the world’s population resides in areas where air quality exceeds WHO guidelines. Exposure to indoor pollution results in severe health outcomes in children and adults, such as stroke, ischemic heart disease, chronic obstructive pulmonary disease (COPD), and lung cancer. These pollutants can adversely affect the respiratory system and cause cancer & eye diseases, such as conjunctivitis, glaucoma, cataracts, and age-related macular degeneration (AMD). Every year, 4.2 million people die from ambient pollution worldwide (Source: WHO). Moreover, 3.8 million people die from household exposure to smoke from fuels and dirty cookstoves (Source: WHO). Such numbers are expected to increase the demand for respiratory care devices.
Growth Opportunities: Cost efficiency of home care services
The increasing healthcare costs have driven a shift in patient preference for home-based treatments. Products such as nebulizers, ventilators, and continuous positive airway pressure (CPAP) devices are used by patients to treat, diagnose, and monitor various respiratory diseases in home care settings. These devices, along with home care services, provide cost-effective healthcare to patients.
Restraints: Excessive purchase of ventilators during COVID-19
Due to the surge in the purchase of ventilators in 2020, some hospitals will not need new ventilators in the coming years, as the life span is ~7-8 years. According to the Medical Device Network, in 2020, the global market for critical care and transport ventilators increased by over 300% due to a sudden surge in demand for treating COVID-19 patients. In April 2020, Koninklijke Philips N.V. (Netherlands) and the US government collaborated to give rapid access to critical materials and components and logistics and regulatory approvals to rapidly increase ventilator production. Similarly, the Ministry of Health Argentina bought all the available ventilators. The government directed the two local ventilator manufacturing companies in Argentina—Leistung Engineering Pvt. Ltd. and Tecme SA—to halt all exports and sell all their products to the government. According to the Ministry of Health in India, to supplement the country's ventilator support resources for COVID-19 patients, the central government sourced 10,000 ventilators from China and placed orders for 40,000 ventilators to be produced domestically (March 2020). Orders for ventilators were also signed with global firms such as Hamilton Medical (Switzerland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Drägerwerk AG & CO. KGAA (Germany), as well as Indian automobile manufacturers.
The rapid growth in the global geriatric population, rising incidence of respiratory diseases (including COPD and asthma), and the cost-effective nature of home care devices and services (compared to hospital visits) are the key factors driving the home healthcare market. Moreover, the high growth potential in emerging markets, healthcare decentralization, and the evolution of miniaturized devices are the other major factors expected to provide significant growth opportunities to players offering ventilation products and services for home care settings.
Challenges: Harmful effects of certain respiratory devices on neonates
Mechanical ventilators provide respiratory care to neonates; however, these devices can also cause chronic lung injury that may result in bronchopulmonary dysplasia (a major complication in preterm babies) and bronchial intubation, which are the common causes of mortality during ventilator assistance. There have been cases where mechanical ventilation has led to blindness among preterm babies due to excess oxygen. Companies are using surfactants to reduce the harmful effects of ventilation and prevent infection. They are also educating healthcare professionals on the appropriate use of these devices to decrease the harmful effects of ventilation.
Noninvasive ventilation techniques such as nasal continuous positive airway pressure (CPAP) are preferred over invasive ventilation to reduce these complications. However, most vulnerable infants may still require intubation and invasive mechanical ventilation. Despite the availability of advanced neonatal ventilators, invasive mechanical ventilation remains a risk and can lead to bronchopulmonary dysplasia (BPD).
Low- and middle-income countries lack specialized respiratory care infrastructure for infants. The unavailability of specialized ventilators for infants or adult ventilators as an alternative to infant respiratory devices results in numerous infant deaths. Also, these countries lack awareness about technological advancements and developments in neonatal ventilators.
Based on type, the high-end ICU ventilators segment accounted of the intensive care ventilator market
In 2021, the high-end ICU ventilators segment accounted of the intensive care ventilators market. The demand for high-end ICU ventilators largely comes from large hospitals in developed countries. The high costs of these restrict greater adoption in small and mid-size hospitals with limited ICU beds. However, improving healthcare infrastructure and rising healthcare expenditure in developing countries are expected to drive the market for high-end ICU ventilators.
Based on mode, the combined-mode ventilators segment will grow at the highest CAGR during the forecast period
The combined-mode ventilators segment will continue to dominate the market in 2027, growing at the highest CAGR during the forecast period. Companies are now focusing on manufacturing combined-mode ventilators as it offers the benefits of pressure control ventilation with lowest inspiratory pressure for all breaths, better oxygenation, along with the security of consistent tidal volume.
Based on end user, home care settings segment will grow at the highest CAGR during the forecast period
In 2021, home care settings segment will grow at the highest CAGR during the forecast period. Technological advancements in ventilation devices have enabled the development of compact and lightweight devices that are easier to carry and operate. These advancements, coupled with increasing awareness and acceptance of home care devices among patients, are expected to propel the growth of the home care settings segment during the forecast period.
North America is expected to account for the largest share of the ventilator market in 2021
To know about the assumptions considered for the study, download the pdf brochure
North America is expected to account for the largest share of the ventilator market in 2021. The rising geriatric population, increasing COVID-19 patient volume, high prevalence of smoking, high prevalence of respiratory diseases, highly developed healthcare system, and high healthcare expenditure are the other major factors responsible for the large share of North America in the ventilator market.
Ventilator Market Key Players
Key players in the Ventilators Market: Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK), Allied Healthcare Products, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Avasarala Technologies Ltd (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), Hill-Rom Holdings, Inc. (US), HEYER Medical AG (Germany), and Leistung Engineering Pvt. Ltd. (Argentina).
Ventilator Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$3.9 billion |
|
Estimated Value by 2027 |
$5.4 billion |
|
Growth Rate |
Poised to grow at a CAGR of 6.3% |
|
Largest Share Segments |
Type - High-end ICU ventilators Mode - Combined-mode ventilators End User - Home care settings |
|
Market Report Segmentation |
Mobility, Type, Interface, Mode, End User, and Regional & Global Level |
|
Growth Drivers |
|
|
Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
The study categorizes the ventilator market based on mobility, type, interface, mode, end user and regional & global level.
By Mobility
-
Intensive Care Ventilators
- High-end ICU ventilators
- Mid-end ICU ventilators
- Basic ICU Ventilators
- Portable/transportable ventilators
By Type
- Adult/pediatric Ventilators
- Neonatal/infant ventilators
By Interface
- Invasive Ventilators
- Non-invasive Ventilators
By Mode
- Combined Mode Ventilators
- Volume Mode Ventilators
- Pressure Mode Ventilators
- Other modes of ventilators
By End User
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Australia
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
Recent Developments:
- In June 2021, Vyaire Medical, Inc. partnered with GenWorks Healthcare Limited. The partnership in India expands the company's footprint and provides greater accessibility to high-quality pulmonary screening, testing, and treatment.
- In November 2020, Koninklijke Philips N.V. partnered with African Union. This partnership led to the launch of a first-of-its-kind ventilator exchange program to allow the replacement of outdated intensive care unit (ICU) ventilators.
- In May 2020, Vyaire Medical, Inc. partnered with Spirit AeroSystems. This partnership helped accelerate the production of ventilators and other related respiratory equipment.
Frequently Asked Questions (FAQ):
What is the size of Ventilator Market?
The ventilator market size is projected to reach USD 5.4 billion in 2027, growing at a CAGR of 6.3%.
What are the major growth factors of Ventilator Market?
In recent years, the ventilators market has evolved significantly due to technological advancements, such as the development of advanced portable ventilators and improvements in the sensor technologies used in ventilators. The increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, growing preference for home-based oxygen therapy, and the outbreak of infectious diseases affecting the respiratory system are expected to drive market growth. The emergence of home healthcare has expanded growth opportunities for the ventilators market. However, shortage of skilled medical workers and the excessive purchase of ventilators are factors expected to restrain the market growth to a certain extent in the coming years.
Who all are the prominent players of Ventilator Market?
Key players in the Ventilators Market: Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK), Allied Healthcare Products, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Avasarala Technologies Ltd (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), Hill-Rom Holdings, Inc. (US), HEYER Medical AG (Germany), and Leistung Engineering Pvt. Ltd. (Argentina).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 32)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 VENTILATORS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.4 CURRENCY USED
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 37)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V.
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: VENTILATOR MARKET (2021)
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2022–2027)
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 12 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 SCOPE-RELATED LIMITATIONS
2.6.2 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: VENTILATORS MARKET
3 EXECUTIVE SUMMARY (Page No. - 52)
FIGURE 14 VENTILATOR MARKET, BY MOBILITY, 2022 VS. 2027 (USD MILLION)
FIGURE 15 VENTILATORS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GLOBAL MARKET, BY INTERFACE, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GLOBAL MARKET, BY MODE, 2022 VS. 2027 (USD MILLION)
FIGURE 18 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 19 GEOGRAPHICAL SNAPSHOT OF GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 56)
4.1 VENTILATOR MARKET OVERVIEW
FIGURE 20 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET
4.2 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY AND COUNTRY (2021)
FIGURE 21 INTENSIVE CARE VENTILATORS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2021
4.3 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 GLOBAL MARKET: REGIONAL MIX
FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET IN 2027
5 MARKET OVERVIEW (Page No. - 59)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 VENTILATOR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising burden of respiratory diseases
5.2.1.1.1 Increasing incidence of COPD and asthma
5.2.1.1.2 High prevalence of tobacco smoking
TABLE 3 PREVALENCE AND DEATHS CAUSED DUE TO SMOKING (2022)
5.2.1.2 Urbanization and rising pollution levels
FIGURE 25 ANNUAL DEATHS CAUSED BY HOUSEHOLD & AMBIENT AIR POLLUTION, BY DISEASE TYPE
5.2.1.3 Rising obesity cases due to sedentary lifestyles
5.2.1.4 Rapid growth in geriatric population worldwide
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION (2010-2020)
5.2.1.5 Growing preference for home care settings
5.2.1.6 Rising number of preterm births
FIGURE 27 TOP COUNTRIES WITH HIGHEST NUMBER OF PRETERM BIRTHS (2018)
FIGURE 28 TOP COUNTRIES WITH HIGHEST PRETERM BIRTHS PER 100 LIVE BIRTHS (2018)
5.2.1.7 Outbreak of infectious respiratory diseases
5.2.2 RESTRAINTS
5.2.2.1 Shortage of skilled medical workers
5.2.2.2 Excessive purchase of ventilators during COVID-19
5.2.2.3 Reimbursement concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Cost efficiency of home care services
5.2.3.2 Growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Low awareness and unavailability of adequate resources in emerging economies
5.2.4.2 Harmful effects of certain respiratory devices on neonates
5.3 INDUSTRY TRENDS
TABLE 4 VENTILATORS MARKET: MARKET CONSOLIDATION AND RISING DEMAND FOR PORTABLE VENTILATORS ARE MAJOR TRENDS
5.3.1 RISING DEMAND FOR ADVANCED PORTABLE & COMPACT VENTILATORS
5.3.2 MARKET CONSOLIDATION
FIGURE 29 RECENT ACQUISITIONS IN GLOBAL MARKET
5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS
5.3.4 INCREASING ADOPTION OF NONINVASIVE VENTILATORS
5.3.5 ENTRY OF NON-MEDICAL COMPANIES TO SUPPLEMENT RISING DEMAND FOR VENTILATORS
5.4 TECHNOLOGY ANALYSIS
5.4.1 ARTIFICIAL INTELLIGENCE IN GLOBAL MARKET
5.4.1.1 Introduction
5.4.1.2 Future of healthcare—Big data and AI
5.4.1.3 Knowledge-based systems for ventilation management
FIGURE 30 AI INTEGRATION FOR VENTILATORS
5.4.1.4 COVID-19 to drive demand for AI-enabled ventilators
5.4.2 SENSOR TECHNOLOGIES IN VENTILATORS
5.4.2.1 Introduction
5.4.2.2 Flow sensors
5.4.2.3 Oxygen sensors
5.4.2.4 Pressure sensors
5.4.3 TECHNOLOGIES WITH HIGH-GROWTH POTENTIAL
5.4.3.1 E-nose technology
5.4.3.2 MEMS technology
5.4.3.3 Electrochemical technology
5.4.3.4 Paramagnetic technology
5.4.3.5 Wireless gas sensor technology
5.5 FACTOR ANALYSIS
5.5.1 POPULATION SCENARIO
FIGURE 31 TOTAL POPULATION, BY COUNTRY (2010−2020)
FIGURE 32 URBAN POPULATION, BY COUNTRY/REGION (2010−2019)
FIGURE 33 GERIATRIC POPULATION (AGED ABOVE 65 YEARS) (2010-2019)
5.5.2 HEALTHCARE EXPENDITURE
FIGURE 34 US ACCOUNTED FOR HIGHEST HEALTHCARE EXPENDITURE (% OF GDP) (2010-2018)
5.6 PRICING ANALYSIS
TABLE 5 AVERAGE SELLING PRICE OF VENTILATORS OFFERED BY LEADING PLAYERS
5.7 VALUE CHAIN ANALYSIS
FIGURE 35 VALUE CHAIN: VENTILATORS MARKET
5.8 ECOSYSTEM MAPPING
FIGURE 36 GLOBAL MARKET: ECOSYSTEM ANALYSIS
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 37 GLOBAL MARKET: STAKEHOLDERS IN SUPPLY CHAIN
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 INTENSITY OF COMPETITIVE RIVALRY
5.11 REGULATORY ANALYSIS
5.11.1 NORTH AMERICA
5.11.1.1 US
5.11.1.2 Canada
5.11.2 EUROPE
5.11.3 ASIA PACIFIC
5.11.3.1 Japan
5.11.3.2 China
5.11.3.3 India
5.12 PATENT ANALYSIS
5.12.1 PATENT PUBLICATION TRENDS FOR VENTILATORS
FIGURE 38 GLOBAL PATENT PUBLICATION TRENDS IN THE VENTILATORS MARKET, 2015–2022
5.12.2 TOP APPLICANTS (COMPANIES) OF VENTILATOR PATENTS
FIGURE 39 TOP COMPANIES THAT APPLIED FOR VENTILATOR PATENTS (2015–2022)
5.12.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN GLOBAL MARKET
FIGURE 40 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR VENTILATOR PATENTS, 2015–2022
5.13 TRADE ANALYSIS
TABLE 7 VENTILATOR EXPORT AND IMPORT DATA, BY COUNTRY (2020)
5.14 CASE STUDY ANALYSIS
TABLE 8 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. DEVELOPING ECONOMIES
TABLE 9 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS
6 VENTILATOR MARKET, BY MOBILITY (Page No. - 89)
6.1 INTRODUCTION
TABLE 10 VENTILATORS MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
6.2 INTENSIVE CARE VENTILATORS
TABLE 11 INTENSIVE CARE VENTILATORS: KEY PRODUCTS
TABLE 12 INTENSIVE CARE VENTILATOR MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 14 INTENSIVE CARE MARKET, BY COUNTRY, 2020–2027 (UNITS)
6.2.1 HIGH-END ICU VENTILATORS
6.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market
TABLE 15 HIGH-END ICU VENTILATORS: KEY PRODUCTS
TABLE 16 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 17 HIGH-END ICU MARKET, BY COUNTRY, 2020–2027 (UNITS)
6.2.2 MID-END ICU VENTILATORS
6.2.2.1 Rising demand due to COVID-19
TABLE 18 MID-END ICU VENTILATORS: KEY PRODUCTS
TABLE 19 MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 20 MID-END ICU MARKET, BY COUNTRY, 2020–2027 (UNITS)
6.2.3 BASIC ICU VENTILATORS
6.2.3.1 High usage in ACCs owing to low costs and availability
TABLE 21 BASIC ICU VENTILATORS: KEY PRODUCTS
TABLE 22 BASIC ICU VENTILATOR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 23 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2020–2027 (UNITS)
6.3 PORTABLE/TRANSPORTABLE VENTILATORS
6.3.1 COMPACT DEVICES FOR MECHANICAL VENTILATION TO PROPEL MARKET GROWTH
TABLE 24 PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS
TABLE 25 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 26 PORTABLE/TRANSPORTABLE MARKET, BY COUNTRY, 2020–2027 (UNITS)
7 VENTILATOR MARKET, BY TYPE (Page No. - 103)
7.1 INTRODUCTION
TABLE 27 VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
7.2 ADULT/PEDIATRIC VENTILATORS
7.2.1 ADULT/PEDIATRIC VENTILATORS ACCOUNTED FOR THE LARGEST SHARE OF THE VENTILATORS MARKET IN 2021
TABLE 28 ADULT/PEDIATRIC VENTILATORS: KEY PRODUCTS
TABLE 29 ADULT/PEDIATRIC VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 NEONATAL/INFANT VENTILATORS
7.3.1 RISING TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO SUPPORT MARKET GROWTH
TABLE 30 NEONATAL/INFANT VENTILATORS: KEY PRODUCTS
TABLE 31 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 VENTILATOR MARKET, BY INTERFACE (Page No. - 108)
8.1 INTRODUCTION
TABLE 32 VENTILATORS MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
8.2 INVASIVE VENTILATORS
8.2.1 INCREASING CASES OF COVID-19 AND RISING PREVALENCE OF RESPIRATORY DISEASES TO SUPPORT MARKET GROWTH
TABLE 33 INVASIVE VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 NONINVASIVE VENTILATORS
8.3.1 CONSTANT AIRFLOW COMBINED WITH RELIABLE MECHANICAL DESIGN TO DRIVE MARKET
TABLE 34 NONINVASIVE VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9 VENTILATOR MARKET, BY MODE (Page No. - 112)
9.1 INTRODUCTION
TABLE 35 VENTILATORS MARKET, BY MODE, 2020–2027 (USD MILLION)
9.2 COMBINED-MODE VENTILATORS
9.2.1 HYBRID MODE COMBINING FEATURES OF VOLUME-TARGETED & PRESSURE-TARGETED VENTILATORS
TABLE 36 COMBINED-MODE VENTILATORS: KEY PRODUCTS
TABLE 37 COMBINED-MODE VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 VOLUME-MODE VENTILATORS
9.3.1 ACV AND SIMV VENTILATORS INCLUDED IN THIS SEGMENT
TABLE 38 VOLUME-MODE VENTILATORS: KEY PRODUCTS
TABLE 39 VOLUME-MODE VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 PRESSURE-MODE VENTILATORS
9.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE AND IMPROVED PATIENT COMFORT
TABLE 40 PRESSURE-MODE VENTILATORS: KEY PRODUCTS
TABLE 41 PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 OTHER VENTILATOR MODES
TABLE 42 OTHER VENTILATOR MODES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10 VENTILATOR MARKET, BY END USER (Page No. - 119)
10.1 INTRODUCTION
TABLE 43 VENTILATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2 HOSPITALS AND CLINICS
10.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET
TABLE 44 GLOBAL MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
10.3 AMBULATORY CARE CENTERS
10.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE GROWTH
TABLE 45 GLOBAL MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
10.4 EMERGENCY MEDICAL SERVICES
10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO SUPPORT MARKET GROWTH
TABLE 46 GLOBAL MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
10.5 HOME CARE SETTINGS
10.5.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET
TABLE 47 GLOBAL MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
11 VENTILATOR MARKET, BY REGION (Page No. - 126)
11.1 INTRODUCTION
FIGURE 41 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
TABLE 48 VENTILATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 42 NORTH AMERICA: VENTILATOR MARKET SNAPSHOT
TABLE 49 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 NORTH AMERICA: MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 NORTH AMERICA: VENTILATOR MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 54 NORTH AMERICA: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 55 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.1 US
11.2.1.1 Large patient pool due to Covid-19 to drive market
TABLE 56 US: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 57 US: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 58 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 US: VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 60 US: VENTILATOR MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 61 US: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 62 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Increasing incidence of COPD to drive market
TABLE 63 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
TABLE 64 CANADA: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 65 CANADA: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 66 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 CANADA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 CANADA: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 69 CANADA: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 70 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3 EUROPE
TABLE 71 EUROPE: VENTILATOR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 72 EUROPE: VENTILATORS MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 73 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 EUROPE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 EUROPE: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 76 EUROPE: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 77 EUROPE: VENTILATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Rising healthcare spending to increase demand for high-end ventilators
TABLE 78 GERMANY: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 79 GERMANY: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 80 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 GERMANY: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 GERMANY: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 83 GERMANY: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 84 GERMANY: VENTILATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 Highly advanced healthcare system to drive adoption of ventilators in hospitals
TABLE 85 FRANCE: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 86 FRANCE: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 87 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 FRANCE: VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 FRANCE: VENTILATOR MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 90 FRANCE: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 91 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.3 UK
11.3.3.1 Increasing healthcare expenditure to drive market growth
TABLE 92 UK: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 93 UK: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 94 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 UK: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 UK: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 97 UK: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 98 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.4 ITALY
11.3.4.1 High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market
TABLE 99 ITALY: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 100 ITALY: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 101 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 ITALY: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ITALY: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 104 ITALY: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 105 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 High burden on state-run health insurance system and poor healthcare infrastructure to restrain market
TABLE 106 SPAIN: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 107 SPAIN: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 108 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 SPAIN: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 SPAIN: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 111 SPAIN: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 112 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.6 NETHERLANDS
11.3.6.1 Increasing COVID-19 patient population to support market
TABLE 113 NETHERLANDS: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 114 NETHERLANDS: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 115 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 NETHERLANDS: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 NETHERLANDS: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 118 NETHERLANDS: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 119 NETHERLANDS: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 120 REST OF EUROPE: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 121 REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 REST OF EUROPE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 REST OF EUROPE: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 124 REST OF EUROPE: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 125 REST OF EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 43 ASIA PACIFIC: VENTILATOR MARKET SNAPSHOT
TABLE 126 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 127 ASIA PACIFIC: MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 128 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 ASIA PACIFIC: VENTILATOR MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 131 ASIA PACIFIC: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Established healthcare system to increase adoption of respiratory care devices
TABLE 133 JAPAN: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 134 JAPAN: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 135 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 JAPAN: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 JAPAN: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 138 JAPAN: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 139 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Healthcare development and initiatives to curb COVID-19 to drive market
TABLE 140 CHINA: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 141 CHINA: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 142 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 CHINA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 CHINA: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 145 CHINA: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION).
TABLE 146 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Rising focus of global players on Indian market to drive adoption of advanced ventilators
TABLE 147 INDIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 148 INDIA: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 149 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 INDIA: VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 INDIA: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 152 INDIA: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 153 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 High prevalence of chronic lung diseases to drive demand for ventilators
TABLE 154 AUSTRALIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET
TABLE 155 AUSTRALIA: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 156 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 AUSTRALIA: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 159 AUSTRALIA: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 160 AUSTRALIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
TABLE 161 REST OF ASIA PACIFIC: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 162 REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 163 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 REST OF ASIA PACIFIC: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 165 REST OF ASIA PACIFIC: VENTILATOR MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 166 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5 LATIN AMERICA
TABLE 167 LATIN AMERICA: VENTILATOR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 168 LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 169 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 LATIN AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 Healthcare infrastructure improvement to support market growth
TABLE 174 BRAZIL: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 175 BRAZIL: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 176 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 BRAZIL: VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 BRAZIL: MARKET, BY INTERFACE, 82020–2027 (USD MILLION)
TABLE 179 BRAZIL: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 180 BRAZIL: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 Rising obesity to increase incidence rate of respiratory diseases
TABLE 181 MEXICO: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 182 MEXICO: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 183 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 MEXICO: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 MEXICO: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 186 MEXICO: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 187 MEXICO: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.3 ARGENTINA
11.5.3.1 Incidence of severe acute respiratory infections to drive market
TABLE 188 ARGENTINA: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 189 ARGENTINA: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 190 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 ARGENTINA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 ARGENTINA: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 193 ARGENTINA: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 194 ARGENTINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 195 REST OF LATIN AMERICA: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 196 REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 197 REST OF LATIN AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 REST OF LATIN AMERICA: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 199 REST OF LATIN AMERICA: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 200 REST OF LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET
TABLE 201 MIDDLE EAST & AFRICA: VENTILATOR MARKET, BY MOBILITY, 2020–2027 (USD MILLION)
TABLE 202 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 203 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: MARKET, BY INTERFACE, 2020–2027 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: MARKET, BY MODE, 2020–2027 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 195)
12.1 INTRODUCTION
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
12.3 REVENUE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VENTILATOR MARKET
12.4 MARKET SHARE ANALYSIS
FIGURE 45 VENTILATOR MARKET SHARE ANALYSIS, BY KEY PLAYERS (2021)
12.5 COMPANY PRODUCT FOOTPRINT
12.5.1 FOOTPRINT OF COMPANIES, BY MOBILITY
12.5.2 FOOTPRINT OF COMPANIES, BY TYPE
12.5.3 FOOTPRINT OF COMPANIES, BY INTERFACE
12.5.4 FOOTPRINT OF COMPANIES, BY MODE
12.5.5 FOOTPRINT OF COMPANIES, BY END USER
12.5.6 REGIONAL FOOTPRINT OF COMPANIES
12.6 VENTILATOR MARKET: R&D EXPENDITURE
FIGURE 46 R&D EXPENDITURE OF KEY PLAYERS IN VENTILATOR MARKET (2020 VS. 2021)
12.7 COMPANY EVALUATION MATRIX
12.7.1 STARS
12.7.2 EMERGING LEADERS
12.7.3 PERVASIVE PLAYERS
12.7.4 PARTICIPANTS
FIGURE 47 VENTILATOR MARKET: COMPANY EVALUATION MATRIX
12.8 COMPETITIVE LEADERSHIP MAPPING (STARTUPS/SMES)
12.8.1 PROGRESSIVE COMPANIES
12.8.2 STARTING BLOCKS
12.8.3 RESPONSIVE COMPANIES
12.8.4 DYNAMIC COMPANIES
FIGURE 48 VENTILATOR MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
12.9 COMPETITIVE BENCHMARKING
TABLE 207 VENTILATOR MARKET: KEY STARTUPS/SMES
12.1 COMPETITIVE SCENARIO
12.10.1 PRODUCT LAUNCHES
TABLE 208 VENTILATOR MARKET: PRODUCT LAUNCHES (JANUARY 2019-OCTOBER 2022)
12.10.2 DEALS
TABLE 209 VENTILATOR MARKET: DEALS (JANUARY 2019-OCTOBER 2022)
12.10.3 OTHER DEVELOPMENTS
TABLE 210 VENTILATOR MARKET: OTHER DEVELOPMENTS (JANUARY 2019-OCTOBER 2022)
13 COMPANY PROFILES (Page No. - 212)
13.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
13.1.1 KONINKLIJKE PHILIPS N.V.
TABLE 211 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 49 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
13.1.2 RESMED
TABLE 212 RESMED INC.: BUSINESS OVERVIEW
FIGURE 50 COMPANY SNAPSHOT: RESMED (2022)
13.1.3 MEDTRONIC
TABLE 213 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 51 COMPANY SNAPSHOT: MEDTRONIC (2022)
13.1.4 VYAIRE MEDICAL, INC.
TABLE 214 VYAIRE MEDICAL, INC: BUSINESS OVERVIEW
13.1.5 GETINGE AB
TABLE 215 GETINGE AB: BUSINESS OVERVIEW
FIGURE 52 COMPANY SNAPSHOT: GETINGE AB (2021)
13.1.6 DRÄGERWERK AG & CO. KGAA
TABLE 216 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW
FIGURE 53 COMPANY SNAPSHOT: DRÄGERWERK AG & CO. KGAA (2021)
13.1.7 ICU MEDICAL INC.
TABLE 217 ICU MEDICAL INC: BUSINESS OVERVIEW
FIGURE 54 COMPANY SNAPSHOT: SMITHS GROUP PLC (2021)
13.1.8 HAMILTON MEDICAL
TABLE 218 HAMILTON MEDICAL: BUSINESS OVERVIEW
13.1.9 GE HEALTHCARE
TABLE 219 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 55 COMPANY SNAPSHOT: GE HEALTHCARE (2021)
13.2 OTHER PLAYERS
13.2.1 AIR LIQUIDE
TABLE 220 AIR LIQUIDE: BUSINESS OVERVIEW
FIGURE 56 COMPANY SNAPSHOT: AIR LIQUIDE (2021)
13.2.2 ASAHI KASEI CORPORATION
TABLE 221 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
FIGURE 57 COMPANY SNAPSHOT: ASAHI KASEI CORPORATION (2021)
13.2.3 ALLIED HEALTHCARE PRODUCTS, INC.
TABLE 222 ALLIED HEALTH PRODUCTS, INC.: BUSINESS OVERVIEW
FIGURE 58 COMPANY SNAPSHOT: ALLIED HEALTH PRODUCTS, INC. (2021)
13.2.4 NIHON KOHDEN CORPORATION
TABLE 223 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
FIGURE 59 COMPANY SNAPSHOT: NIHON KOHDEN CORPORATION (2021)
13.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
TABLE 224 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: BUSINESS OVERVIEW
FIGURE 60 COMPANY SNAPSHOT: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. (2021)
13.2.6 SKANRAY TECHNOLOGIES, LTD.
TABLE 225 SKANRAY TECHNOLOGIES, LTD: BUSINESS OVERVIEW
FIGURE 61 COMPANY SNAPSHOT: SKANRAY TECHNOLOGIES, LTD. (2020)
13.2.7 BAXTER INTERNATIONAL, INC.
TABLE 226 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
13.2.8 AXCENT MEDICAL GMBH
TABLE 227 AXCENT MEDICAL GMBH: BUSINESS OVERVIEW
13.2.9 METRAN CO., LTD.
TABLE 228 METRAN CO., LTD.: BUSINESS OVERVIEW
13.2.10 MAGNAMED
TABLE 229 MAGNAMED: BUSINESS OVERVIEW
13.2.11 LEISTUNG INGENIERÍA SRL
TABLE 230 LEISTUNG INGENIERÍA SRL: BUSINESS OVERVIEW
13.2.12 AVASARALA TECHNOLOGIES LIMITED
13.2.13 AIRON CORPORATION
13.2.14 TRITON ELECTRONIC SYSTEMS LTD.
13.2.15 BIO-MED DEVICES, INC.
13.2.16 HEYER MEDICAL AG
*Details on Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 260)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the ventilator market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side and demand side are detailed below.
A breakdown of the primary respondents is provided below:
Breakdown of Primary Interviews: Supply-Side Participants, by Company Type, Designation, and Region
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primaries include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =
To know about the assumptions considered for the study, download the pdf brochure
Breakdown of Primary Interviews: Demand-Side Participants by End User, Designation, and Region
Note: Others include department heads, research scientists, and professors.
Market Size Estimation
The total size of the ventilator market was arrived at after data triangulation from three different approaches, as mentioned below. After each approach, the weighted average of all approaches was taken based on the level of assumptions used in each approach.
Data Triangulation
After arriving at the market size, the total market was divided into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.
Objectives of the Study
- To describe, analyze, and forecast the ventilators market by type, mobility, interface, mode of ventilation, end user, and region
- To describe and forecast the ventilators market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the ventilators market
- To strategically analyze the ecosystem, regulations, patent landscape, trade landscape, and case studies pertaining to the market under study
- To provide a detailed overview of the supply chain pertaining to the ventilator market ecosystem, along with the average selling prices of different types of ventilators
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies2 in the ventilators market
- To analyze competitive developments such as partnerships, collaborations, agreements and acquisitions, product launches, and expansions in the ventilators market
Available customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the RoE ventilator market into Austria, Finland, and others
- Further breakdown of the RoLATAM ventilator market into Colombia, Chile, and others
Competitive Landscape Assessment
- Market share analysis for the North America and Europe region, which provides market shares of the top 3–5 key players in the ventilator market
- Competitive leadership mapping for established players in the US
Growth opportunities and latent adjacency in Ventilator Market